J. S.
 Sr. Vice President,
Biotechnology
Nouscom
Italy
Biography
Dr. John Shiver is Sr. Vice President, Research and Development with Sanofi Pasteur since 2013. He has 22 years of vaccine research and development experience from Merck where he also led Vaccine Research for 9 years following four years as Senior Staff Fellow in the Experimental Immunology Branch of the National Cancer Institute, National Institutes of Health.Dr. Shiver has gained international recognition in the scientific community for his leadership of Merck’s novel HIV vaccine research program. He is the author of more than 150 articles that have been published in leading scientific journals, including 19 in the high impact journals Science, Nature, Cell, and the Proceedings of the National Academy of Sciences. In addition, Dr. Shiver is a co-author of 68 awarded patents covering his contributions in the field of novel vaccine development. He is a Fellow of the American Academy of Microbiology, International Society for Vaccines, and was recognized by the Financial Times.
Research Interest
Biotechnology
